Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion type Assertion NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_head.
- NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion wasGeneratedBy ECO_0000203 NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_provenance.
- NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion wasDerivedFrom befree-2016 NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_provenance.
- NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion SIO_000772 19815628 NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_provenance.
- NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion evidence source_evidence_literature NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_provenance.
- NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_assertion description "[Q-HSC activation in vitro (culture) and in vivo (CCl(4)-induced cirrhosis) resulted in decreased expression of Hh-interacting protein (Hhip, an Hh antagonist), the EMT inhibitors bone morphogenic protein (BMP-7) and inhibitor of differentiation (Id2), the adherens junction component E-cadherin, and epithelial keratins 7 and 19 and increased expression of Gli2 (an Hh target gene) and mesenchymal markers, including the mesenchyme-associated transcription factors Lhx2 and Msx2, the myofibroblast marker alpha-smooth muscle actin, and matrix molecules such as collagen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768329.RAPrrS0HsQYQoX7INtHySn1WIRDKK927_gnbbvDrvFjHk130_provenance.